Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing
Author:
Affiliation:
1. Division of Hematology; Mayo Clinic; Rochester Minnesota
2. Division of Hematopathology, Department of Laboratory Medicine; Mayo Clinic; Rochester Minnesota
3. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester Minnesota
Funder
The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA
CTSA
National Center for Advancing Translational Sciences
Publisher
Wiley
Subject
Hematology
Reference25 articles.
1. Refractory anemia with ring sideroblasts and RARS with thrombocytosis;Patnaik;Am J Hematol,2015
2. Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations;Jeromin;Haematologica,2015
3. Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis;Broseus;Haematologica,2012
4. SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value;Patnaik;Blood,2012
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis;Leukemia;2024-05-07
2. Predicting survival in myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis;2024-02-15
3. Myelodysplastic/Myeloproliferative Neoplasms;The EBMT Handbook;2024
4. Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape;International Journal of Molecular Sciences;2023-12-12
5. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3